Avestria Ventures — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Avation Medical manufactures the Vivally System, an FDA-cleared wearable device that uses transcutaneous tibial nerve stimulation to treat overactive bladder and urge urinary incontinence in at-home 30-minute sessions.
Digital HealthHealthtechMedical DevicesValencia, US
Jill Schiaparelli(Executive Officer, Director)inKevin Wasserstein(Director)
BoardThomas Shehab, MD(Director)
Co-investorsAngelini VenturesArboretum VenturesShangBay Capital LLC
Axena Health develops digital therapeutic devices for women's pelvic health, specifically treating urinary and fecal incontinence through at-home pelvic floor muscle training.
Digital HealthFemTechHealthtechMedical DevicesAuburndale, US
Samantha Pulliam(CEO and Chief Medical Officer)inVincent Ricci(Executive Officer)Jim O'Connor(Executive Officer)inShacey Petrovic(Executive Officer, Director)inEileen Maus(Executive Officer, Director)in
BoardJonathan Dean(Director)
Co-investorsCatalio Capital Management, LPCross-Border Impact Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.